CAS Number: 245329-02-6 (free base)
Empirical Formula (Hill Notation): C39H60N10O8 · xC2HF3O2
Molecular Weight: 796.96 (free base basis)
Linear Formula: C39H60N10O8 · xC2HF3O2
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to off-white |
form | powder |
InChI | 1S/C39H60N10O8/c1-22(2)17 |
InChI key | KMSCNWHRNILNRJ-JNRWAQIZSA |
Quality Level | 100 ![]() |
shipped in | wet ice |
storage temp. | −20°C |
Amino Acid Sequence: | Phe-Ser-Leu-Leu-Arg-Tyr-N |
Application: | FSLLRY-NH2 trifluoroacetate salt has been used as a protease-activated receptor 2 (PAR2) inhibitor to test its effects on urinary tract infections (UTIs) in a murine model. It has also been used to study the clinical itch datasets from phase 3 clinical trials for moderate-to-severe AD in atopic dermatitis (AD)-associated acute itch flare mice modelin rats. |
Biochem/physiol Actions: | FSLLRY-NH2 is a peptide antagonist of the protease activated receptor 2 (PAR2). The peptide blocks agonist induced itching in rodent models. In cell based assays, the peptide inhibits agonist-induced cardiocyte remodeling, and production of cytokines by endothelial cells. |
Biochem/physiol Actions: | The ability of FSLLRY-NH2 to decrease visceral hypersensitivity (VH) suggests that PAR2 is involved in the maintenance of VH. |
Packaging: | 1 mg in glass bottle |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | −20°C |
UNSPSC | 12352200 |
We are currently working diligently to update our website pricing information for the New Year. If you place an order, you will be acknowledged with any corrected pricing. If you'd like the most current information sooner, please don't hesitate to drop us an email or give us a call and we'd be happy to assist. Thank you for your patience while we are updating.
800-334-7725
office@krackeler.com
Please fill out the form below if you want to request order support from Krackeler Scientific.
You will be contacted with a quote.